Companies / TrueBinding
TrueBinding
United States
TrueBinding develops and provides access to an investigational drug called TB006 for patients with dementia, including Alzheimer's disease
TrueBinding, based in United States, has 1 investor on file, among them ShangBay Capital. Its site was last checked 14 Nov 2026: site answers.
SEC Form D filings
5 filingsFiled by TrueBinding, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from ShangBay Capital
55 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%), Robotics & Hardware (11%), Advanced Materials & Chemicals (4%).
See ShangBay Capital's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get TrueBinding and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when ShangBay Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/truebinding.com/investors
# also
GET /v1/companies/truebinding.com
GET /v1/companies/truebinding.com/news